Study sets benchmark for treatment of advanced cervical cancer
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Frontiers2d
Advances in Diagnosis and Treatment of Endometrial Cancer
Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...
American Cancer Society2d
Key Statistics for Endometrial Cancer
How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...
oncnursingnews3d
Pembrolizumab Shows ORR, Tolerability in Previously Treated Gynecologic Cancer
Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...
The American Journal of Managed Care3d
Changes in Tumor Size Track Advanced RCC Outcomes, Analyses From CLEAR Show
Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...
Cancer Therapy Advisor4d
Pembrolizumab Provides “Robust” Clinical Benefit in Clear Cell Gynecologic Cancer
Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.